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Hair follicles develop and are maintained by multiple
rounds of inductive events involving interactions
among various cell types within the follicles and the
adjacent mesenchyme. Although evidence suggests
that several growth factors, cell adhesion molecules,
and transcriptional regulators are involved in those
cell-cell interactions, the molecular mechanisms reg-
ltlating each pivotal step ofhair follicle development,
such as formation of the hair gernl, root sheath,
sebaceous gland, and hair canal, remain largely un-
known. In this study, we established the antagonistic
monoclonal antibody APA5 against platelet-derived
growth factor (PDGF) receptor-G' (PDGFR-G') and
used it to investigate the role of PDGFR-G' in neona-
tal skin development. In addition to the dermal
Inesenchynte, a known site of PDGFR-G' expression,
immunohistologic staining of neonatal skin detected
transient expression of PDGFR-G' in the perinatal
P latelet-derived growth f.,ctor receptor-a (PDGFR-a) isone of two receptors for platelet-derived growth factors(PDGFs) and biJlds to all isoforms of PDGFs: PDGF-AA, PDGF-AB, and PDGF-BB (Heldul and Wester-mark, 1989; Matsui ef ai, 1989). The pleiotropic effcct
of PDGFs on various ceLl types and the expression ofPDGFR-a in
a variety of tissues throughout embryonic development and post-
natal life suggcst its roles in multiple processes, such as gastrulation
(Mcrcola ef ai, 1990; Orr-Urtregcr and Lonai, 1992; Schatteman el
ai, 1992), vasculogenesis (Beitz el ai, 1991; Holmgrcn ef ai, 1991),
wound hcaling (Hajjar cI ai, 1987; Pierce el ai, 1988; Marikovsky ef
ai, 1993), and glial cell development (Yeh ef ai, 1991; Pringle and
Richardson, 1993; Ban'cs ef ai, 1994). Tn fact, the PhlPh mutant
mouse, which bears a large delction in the gene encoding
PDGFR-a (Stephenson ef ai, 1991), is lethal in embryos because of
multiorgan failure. Dctailed analyses of PhlPh cmbryos by Orr-
Urtreger ef al (1992) and Morrison-Graham cf al (1992) indeed
provided a surprisingly long list of organs affccted by this mutation.
Though a significant correlation betwcen PDGFR-a expression
and a dcfect in each tissuc is implicated by these studies, how
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epiderlnis for several days. On the other hand, li-
gands for PDGFR-G' were detected in epithelial cells
and sebaceous glands of hair follicles. To determine
whether this contiguous expression of PDGF and
PDGFR-G' in neonatal skin plays a functional role, we
injected APA5 into neonates to block the function of
PDGFR-G'. Consistent with the PDGF/PDGFR-G' ex-
pression in the neonatal skin, two defects were in-
duced by this procedure. First, hair canal formation
in the epidermis was severely suppressed. Second, the
growth of dermal connective tissues and of hair
follicles ofpelage hairs was suppressed. These results
indicate that PDGF signals are involved in both the
epiderntis-follicle interaction and the dermal mesen-
chyme-follicle interaction required for hair canal
formation and the growth of the dennal mesen-
chyme, respectively. Key 1II00'ds: PDGFR-G'llra.ir folliclel
APA5. ] Invest Del'll.atol 107:770-777, 1996
PDGFIt-a is mvolved Ul each process remains largely unkJlown.
Moreover, becausc the loss-of-function mutation in the PDGFR-CY.
gene is also lethal in mice in which the PDGFR-{3 (Soriano, 1994),
PDGF-B (Levecn el ai, 1994), and PDGF-A (Westennark, 1995)
genes are disrupted, it is difficult to iJ1Vcstigate the function of these
signals during late embryonic and postnatal development, though a
role has been suspected in processes such as the development of
oligodendrocytes (Yeh ef ai, 1991; Pringle and Richardson, 1993:
Barres cf aI, 1994) or wound healing (H'War el ai, 1987; Pierce er ill,
1988; Marikovsky el ai, 1993).
To address these issucs, we believc that antibody-mediated
manipulation of a PDGFR-a-depcndent proccss would be the be t
stratcgy, as the antibody can dctcct PDGFR-CY.+ cells, and we are
able to verify its function in PDGFR-CY.+ tissues by injecting
antagonistic monoclonal antibodics (MoAbs) at appropriate time.
Indeed, Ollt prcvious studies of postnatal injection of anti-c-Kit
MoAb revealed sevcral proccsscs in which c-Kit has a fimctional
rolc (Yoshinaga et ai, 1991; Macda el ai, 1992; Ogawa ef ai, 1993).
Among these proccsses, the involvemcnt of c-Kit ,in the develop-
ment of intestinal paccmaker cclls was discovered by our antibody-
blocking studies and reconfirmed by analyses of thc TtliII¥" mouse
(Huizinga ef ai, 1995).
To uncover novel dcvelopmcntal processes that require the
PDGFR-a signal, we established an antagonistic anti-murine
PDGFR-a MoAb :lI1d used it to analyze cxpression and function of
the receptor. This study demonstrates that PDGFR-CY. is expres ed
transiently in cpidermal kcratinocytcs of thc ncwborn mouse.
Moreovcr, blocking PDGFR-a at this stagc supprcsses the fonna-
0022-202X/96/S10.50 • Copyright © 1996 by Thc Socicty for Invcstigative Dcrmatology. Inc.
770
VOL. 107, NO.
PDGFRf3-
c-FMS
Flkl
FIk2
IL-7R -
NOVEMBER 19% PDGFR-a EXPR.ES 'ION AND FUNCTION IN THE SKIN 771
A B ,,":;~~
;'6
medium fo-l ~'(}C3
PDGF·AA
~~C:~
(0. I fLglml) fo-l kDa
200
ACK4 H(IOfLglml)
120
APAS
(IOfLglml)
APAS 60
(20fLglml)
2000 4000 6000 8000
Bound cpm
o 0.025 0.050 0.075 0.100
Absorbance at 450 nrn
Figure 1. Binding of APA5 to various receptor proteins. Recombi-
nant chimeric proteins between the Fc portion of human IgG1 and the
extracellular domains of PDGFR-(" POGFR-I3, c-Fms, Flk!., Flk2, or IL-7
receptor were coated on an ELISA plate, and binding of APA5 to each
protein was measured. The absorbance at 450 nm is presented. Each bar
represents the Illean of triplicate assays. En'or bnrs. I11Cal1 ± SO.
cion of the hair canal, dermalmesenchYl11e, and hair follicles. These
results indicate the role ofPDGFR-a in the final step of hair follicle
development, in which both mesenchyme-follicle and epidermis-
follicle interactions arc essential.
MATEIUALS AND METHODS
Animals C57BL/6 mice were purchased from]apan SLC Inc. (Shizuoka.
Japan). Females were paired with males overnight, and vaginal plugs were
checked on the following morning. When a vaginal plug was detected at
noon, t1lat day was designated as day 0.5 of gestation (0.5 d postcoitum).
Production of Anti-Murine PDGFR-a Antibody A cDNA fragment
corresponding to the extracellular domain of murine (m)PDGFR-O' (Do ef
ai, 1992) was generated by reverse transcriptase polymerase chain reaction
amplification of the mRNA prepared from the mouse brain. The primers
were 5'-GAGGTCGACTCAGGAGCTATGGGGACCTCC and 5'-ACT-
Figure 2. Specificity of APA5. (A) inhibition of 12sl_labeled PDGF-AA
binding to BALB/c-3T3 cells by APA5. Each bar represents the arithmetic
mean (:t SD) of triplicate assays. The binding inhibition by APA5 is
comparable to that by cold PDGF-AA. ACK4 is an anti-c-kit antibody used
as a control antibody. (B) \Xlestern blots of the lysate from either
PDGFR-a+ BALB/c-3T3 cells or PDGFR.-a- CYG/SCID7 pro-B cells by
APA5. Molecular mass markers in kDa arc indicated.
GGATCCTCAGATCGCAGAGTGGGAGCCAC. In the first primer. a
Sail site was created from the fourth to the ninth b"se. The rragment was
cloned into the pCRlI vector (Invitrogen, San Diego. CAl. The Sail-Bali/HI
fragment of the cloned PDGFR-O' gene was inserted into CD4Rg (Sudo f1
01, 1993), from which the Xlwl-Ball/1-I1 fragment containing the CD4 gene
was removed. Subsequently, the Xbal-Xlml fragment of this clone was
inserted into the X/wi site of pEF-BOS (a gift rrom S. Nagata, Osaka
l3ioscience Institnte) (Mizushima and Nag"ta. 1.990) and tmnsfected into the
COS1 cell line in Dulbecco's modi tied Eagle's mcdium/F-1.2 mediulTl
(GIBCO, Grand Island, NY) supplelTlented with 1. 'X, Nutridoma-NS
(Boehringer Mannheim. Mannheim. Gernlany). The mPDGFR-O'-hu-
m"n(h) IgG1 recombinant fusion protein was purified rrom tile culntre
supernatant of the transfected COS I cells by Procep-A (Bioprocessing.
Princeton. N]). The spleen cells from a Wistar rat immunized and boosted
with this fusion pro rein were fused with X63.Ag8 cells. as described (Sudo
e' 01, 1.993). The hybridoma supenJatancs were screened by their binding to
the fusion protein and finally selected by the ligand-binding inhibition assay
of PDGFR-O'-positive BALB/c-3T3 cell line (Olashaw ef nl, 1991) to the
'''I-labeled PDGF-AA, as described later.
Figure 3. PDGFR-a expression in the epidermal keratinocytes of neonatal mice. Newborn skins at 0 dpp were immunostained by (A) APA5, (B)
APAS plus mPDGFR-a-hlgG1. chimera protein, or (C) APA5 pillS mPDGFR-~hlgG1 chimera protein. Note that APA5 staining is inhibited by
mPDGFR-0'-hlgG1 chimera protein. Senle bar. 25 J.un.
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Figure 4. Expression ofPDGFR-a in the embryonic and postnatal mouse skin. Immunohistochemistry with APA5 was performed on sections of
the trunk region from C57BL/6 mice at 16.0 d postcoitum (A) and at 0 (B), 1 (C), 3 (D), 5 (E), and 10 (F) dpp. PDGFR-a expression is visualized as a brown
reaction product. PDGFR-O' expression in the epidermal keratinocytes was detected only from 0 to 3 dpp. Note that PDGFR-O' was not detected in the basal
and cornified layers of epidermis of the O-dpp mouse. Scale bars: (A-D), 25 J.Lm; (E,F), 50 J.Lm.
Enzyme-Linked Immunosorbent Assay (ELISA) A 96-well rnicroti-
ter ELISA plate (Becton Dickinson Labware, Lincoln Park, NJ) was coated
with 50 /Jol ofmPDGFR-O'-, mPDGFR-I3- (unpublished), mc-Fms- (Sudo el
01, 1995), m-Flkl- (unpublished), mFlk2- (unpublished), or m1L-7 recep-
tor- (Sudo el 01, 1993) hlgGl chimera proteins (0.5 /Jog per ml). After
blocking the uncoated surface with 1% bovine serum albumin (BSA) in
phosphate-buffered saline (PBS), the cnated plate was incubated with 1 /Jog
APA5 per ml, washed with PBST (0.1% Triton XI00 in PBS), and
incubated with peroxidase-col~ugatedanti-rat IgGl (American Qualex, La
Mirada, CAl. After washing with PBST. 100 /Jol of tetramethylbenzidine
(0.55 M; Dojin Kagaku, Kumamoto, Japan) in 0.5 mM ethylenediamine
tetraacetic acid containing 0.015% HzOz in citrate buffer (0.1 M, pH 5.5)
was added, and bound enzymatic activity was measured by plate reader
(Immuno-Mini NJ-2300; lntermed, Tokyo, Japan).
Ligand-Binding Inhibition Assay With 125I_Labeled PDGF Human
recombinant PDGF-AA (4 /Jog) (GillCO) was radiolabeled to a specific
activity of 4 X 10(, cpm/ng by solid-phase iodination with lodo-Beads
(Pierce, Rockford, IL), as reported previously (Sudo el 01, 1993). Label
incorporation of iodinated product was determined by precipitation with
20% trichloroacetic acid using 1% BSA as a carrier protein. BALB/c-3T3
cells (5 X 105 ) were suspended in 500 /Jol of binding buffer (1 % BSA in
Hanks' balanced salt solution) and incubated for 1 h on ice with binding
buffer only or with hybridoma supernatant or anti-murine c-Kit MoAb
ACK4 (Nishikawa et 01, 1991; Ogawa el 01, 1991) as the negative control, or
with unlabeled PDGF-AA for inhibition with unlabeled ligand. After
incubation, the cells were washed twice with the binding buffer, resus-
pended in 500 /Jol of binding buffer, and incubated with 10 I'M 1251_labeled
PDGF-AA for 1 h on ice. After incubation, free ligand was removed by
repeated washing with centrifugation in the binding buffer, and the 1251
radioactivity bound to the cells was mea ured. After these procedures, only
one hybridoma clone, APA5, was selected; it was typed as an Ig kappa G2a.
Western Blots BALB/c-3T3 and CYG/SCID7 (Ogawa el al. 1989) were
harvested and lysed in protein gel sample buffer. Samples were sonicated
brieAy to shear DNA, then boiled for 5 min before electrophoresis on a 7.5%
sodium dodecyl sulfate-polyacrylamide gel. Proteins were transferred to a
nitroceUulose membrane by electroblotting at IS V for 1 h. The blot was
incubated overnight in hlocking buffer (PBS, pH 7.4: 137 mM NaCI, 8.1
mM NaaHPO.. ' 12 HzO, 2.68 mM KCI. 1.47 mM Kl-IZP04 , containing 1%
BSA and 3% skim milk), then incubated for 1 h with APA5 MoAb at a
concentration of 1 JJ.g pel' ml in the blocking buffer. The blot was washed
three times with PBS containing 0.05% Nonidet P-40 for 10 min and
incubated with peroxidase-conjugated go<u anti-rat IgG (American Qualex)
antibody at a concentration of 1 /Jog per ml in the blocking buffer. The blot
was washed three times with PBS containing 0.05% Nonidet P-40 for 20
min, and PDGFR-O' was visualized using the Enhanced Chemiluminescence
reagent (Amersham, Buckinghamshire, UK). The blot was exposed to Fuji
R." (Fuji Photo Film, Kanagawa, Japan) 1 min at room temperature.
Immunohistochemistry Tissue fixation procedures were basically the
same as described (Yoshida el 01, 1993), but microwave irradiation for
pre-fixation was perfomled for 30 s twice at 600 W in a microwave oven
(ER-365S, Toshiba, Tokyo, Japan). Fixed specimens were embedded in
Figure 5. Contiguous expression of PDGF and
PDGFR-a in the skin. Expression of the ligand for
PDGFR-a in sagittal (A) and transverse (B) sections of
the skin from a 3-dpp C57BL/6 mouse. (C) Expression
ofPDGFR-a in the transverse section of the same skin.
PDGFR-a was detected as described earlier. The ligand
for PDGFR-O' was detected using the mPDGFR-a-
hlgG 1 chimera protein as the first reagent, followed by
perm,;dase-conjugated anti-human IgG. A".oll'''eads in
(A,B) indicate sebaceous gland; an'olll in (B) indicates
outer root sheath. Scale liar, 25 JJ.m.
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polyester wax and sectioned at 5 Jl.m as described (Kusakabe et nt, 1984). 
Irnmunostaining procedures were as describcd (Yoshida et nt. 1993), except 
that a metal-enhanced diaminobenzidine (DAD) substrate kit (Pierce) was 
used without DAD/gold/silver intensification. 
In brief, the sections of skin were incubated in bleaching solution 
(xnethanol:0.2% NaN, :0.6% H2 0 2) for 30 min at room tempcrature to 
block endogcnons peroxidase. The rchydrated sections were then blocked 
by incubating with PBS containing 5% normal goat serum and 1 % BSA for 
20 min at room temperature. incubatcd with anti-PDGFR-a MoAb APA5 
(10 ILg per ml) overnight at 4 cC, and washed three times in PBST for 10 min 
each at room temperature. The primary antibody was developed by 
incubating 1 Jl.g per ml peroxidase-conjugated anti-rat IgG antibody 
(Biosource, Camarillo, CAl for 1 h at room temperature. After washing 
with three exchanges of PBST for 10 min at room temperature, the 
enzymatic reaction with the metal-enhanced DAD substrate kit was allowed 
to proceed until the desired color intensity was reached, and the sections 
were rinsed once in PBST. Finally, the sections were dehydrated with 100% 
methanol and photographed. 
Detection of immunolocalization of all isofom1s (PDGF-AA. -AD, and 
-BB) vvas performed using mPDGFR-a-hlgG1 chimeric protein. In brief, 
rhe section of skin was incubated with mPDGFR-a-hlgG1 protein (20 Jl.g 
per ml) for t 2 h at room tcmperature, then with biotinylatcd anti-human 
IgG (1: 100; American Qualex) for 1 h at room temperature. Next, the 
antigen-antibody complexes were reacted with peroxidase-conjugated 
streptavidin (1 :50; Zymcd, San Francisco, CAl for 1 h at room tcmperature. 
and peroxidase-containing sites were visualized with the metal-enhanced 
DAB substrate kit (Pierce). For demonstration of tissue localization of 
APAS, APA5 (100 Jl.g) was injected into neonatal mice at day 0, and the skin 
from the trunk region was embedded in polyester wax and sectioned at 10 
Jl.I11. The section was stained directly witl1 peroxidase-conjugated anti-rat 
IgG (Biosource), and peroxidase-containing sites were visualized with rhe 
DAB substrate kit (Pierce). After immunostaining. the tissue sections were 
examined under a Zeiss microscope (Axiophot; Carl Zeiss Inc., Jena, 
Germany). 
RESULTS 
Specificity of Anti-Murine PDGFR-O' MoAb APA5 We first 
investigated the binding of APA5 MoAb to PDGFR-a, PDGFR-i3, 
c-Fms, Flk-l, Flk-2, and IL-7 receptor by ELISA using a recombi-
nant chimera protein between human IgGl (hlgG1) and the 
extracellular portion of one of these receptors. The specific binding 
( of each receptor-hlgGl chimera protein to the corresponding 
ligand was confirmed using ' 25I_labeled ligands. APAS bound to 
mPDGFR-a-hlgG1 , but not to any of the other chimera proteins 
(Fig 1). Moreover, it inhibited the binding of 1251_labeled 
PDGF-AA to BALB/c-3T3 at a concentration of20 ILg per ml (Fig 
2A), and it recognized 180-kDa surface proteins (Fig 2B) from 
PDGFR-a+ BALB/c-3T3 cells, but not from the CYG/SCID7 
pro-B cell line. The size of the protein immunoblotted by APA5 in 
BALBI c-3T3 cells is consistent with the size of the receptor 
described in the BALB/c-3T3 cells blotted by polyclonal antibody 
against PDGFR-a (Olashaw e/ ai, 1991) and that of other cell lines, 
for example, human dem1al fibroblast (Hart e/ ai, 1987), and of 
murine osteoblast cell line MC3T3-E1 (Tsukamoto el ai, 1991). 
Transient Expression of PDGFR-O' in Epidennal Keratino-
cytes of Neonatal Mice We investigated whether APA5 stain-
ing can identify tissues in which PDGFR-a expression has hitherto 
not been detected. Immunohistologic staini.ng of neonatal tissues 
showed that epidermal , but not follicular keratinocytes ofnewbom 
mice at 0 d postpartum (dpp), expressed PDGFR-a (Fig 3A). Tlus 
staining was inhibited by the recombinant mPDGFR-a-hlgG1, but 
not by mPDGFR-i3--hlgGl recombinant protein (Fig 3B,q, and 
thus "Was specific to PDGFR-a. In agreement with previous studies 
on adult murine skin by ill sit" hybridization (Orr-Urtreger and 
Lonai, 1992; Schatteman e/ ai, 1992) and on adult human skin by 
immunostaining (Ansel et ai, 1993; Ponten e/ ai, 1994; Akiyama et 
01, 1996), we also detected PDGFR-a expression in the dennis with 
APAS (Fig 4). Its expression in the epidermis, however, has not yet 
been documented. What intrigued us was that PDGFR-a was 
expressed in differentiating keratinocytes only at the neonatal stage 
and never in the epidermis at the later stage. As shown in. Fig 4, 
PDGFR-a expression was wldetectable in the epidermis of the 
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Figure 6. Accessibility of APA5 to the neonatal keratinocyte sur-
face. One hundred micrograms of APA5 was injected into rhe peritoneal 
cavity of the newborn mouse (0 dpp) , and tl1e trunk skin was prepared 16 h 
later. The section was stained by anti-rat IgG to detect APAS in the tissue. 
III add ition to tl1e strongly stained interstitial space of the demus, the 
interkeratinocyte space in tl1e epidermis is clearly stained (nlTOIIIS). 
embryo at 16.5 d postcoitum, but was present in all epidemlallayers 
except the basal and comified layers of the O-dpp mouse. As early 
as 5 dpp, however, PDGFR-a expression disappeared from the 
epidermal layer, though some stained patches remained in the 
comified layer (Fig 4E). Thus, PDGFR-a+ keratinocytes found in 
the neonatal skin seem to disappear rapidly and be replaced by 
PDGFR-a- keratinocytes newly fonned in the epidermal layer. 
Contiguous Expression of PDGFR- O' and its Ligand in the 
Neonatal Skin To localize the ligand for PDGFR-a in neonatal 
skin, we used mPDGFR-a-hlgGl c1umeric protein, wluch binds 
specifically to all forms of ' 251_labeled PDGF (data not shown) . 
Sections of trunk skin of the 2-dpp mouse were incubated with 
mPDGFR-a-hlgGl chimeric protein and visualized with peroxi-
dase-conjugated anti-human IgGl (Fig SA,B) . Whereas the follic-
ular epithelium was also stained, the cells in the sebaceous gland 
were most intensely stained, as described before (Akiyama e/ ai , 
1996). In the transverse sections stained either with t1us chimeric 
protein or with APA5 (Fig SB,q, the ell.l'ression of the ligand in 
hair follicles and of PDGFR-a in mesenchymal cells , particularly 
those adjacent to the follicular epithelium, was contiguous. 
Impaired Hair Development in Neonatal Mice Injected 
With APA5 Several important events in hair follicle develop-
ment continue during perinatal life: rapid elongation of pelage hai.r 
follicles, development of the sebaceous gland, and fonnatiol1 of the 
hair canal. To investigate the possible i.nvolvement ofPDGFR-a in 
these processes, we injected APA5 to block its function during the 
perinatal period. Although it is established in pemphigus that 
antibody can reach desmoglein expressed in epidermal keratino-
cytes (Stanley et ai, 1986; Emery e/ ai, 1995), we tested whether 
keratinocytes in the neonatal mouse aJ'e accessible to intraperito-
neally injected APA5 . As sbown in Fig 6, the dermal layer prepared 
16 h after tile injection was strongly stained by anti-rat IgG. In 
addition, the interkeratinocyte space was stained, suggesting that 
APA5 can reach the slITface of keratinocytes. On the other hand, 
when ACK4, which recognizes tile murine c-Kit and is ryped as rat 
IgG2a, was injected in the same manner, melanocytes in the 
epidermis and hair follicle that express c-kit on tbe cell surface were 
stained by anti-rat IgG antibody. But the interkeratinocyte space 
was not stained by anti-rat IgG antibody (data not shown) . 
Because of tile pleiotropic activity of PDGF, inhibition of 
PDGFR-a function during the neonatal period resulted in high 
lethality. All APA5-treated mice were small, and about twO thirds 
died witllin a week. The most import31H pathologic finding t1lat 
may explain the lethality was hydronephrosis, due to a defect in 
elongation of the collecting duct (Fig 7q. Because PDGFR-a is 
expressed in the intertubular mesenchymal cells (data not shown) , 
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Figure 7. Stunted hair follicle development in APAS-injected mice. Sagitwl sections of the kidneys of untreated (A) and APA5-injected (B) 2-dpp
C57BL/6 mice. An intraperitoneal injection ofl00 !J..g APA5 was given every day after birth. Blocking the PDGFR-O' signal inhibits the development of the
renal collecting tube (data not shown). This defect was not fatal at this age, however. (C) Transverse section of the kidney from an APA5-treared 5-dpp
C57BL/6 mouse. The asterisk indicates an intrarenal cyst. The defect in the development of the collecting rube now became f.,ta!. (D) Control (Itift) and
APA5-injected (right) 3-dpp C57BL/6 mice. An intraperitoneal injection of 100 !J..g APA5 was given each day from 0 dpp to 2 dpp. Note that no substantial
difference is present between APA5-treared and untreated mice at this age. (E-H) Flat-mount preparations of the trunk skill from comrol (E,G) and
APA5-injected 3-dpp C57BL/6 mice (F,H), showing views from outside (E,F) and from inside (G,H). An'ows in H indicate frizzled hairs. Scale bars: (A-C),
200 !J..1l1; (E,F), 100 !J..m; (G,H), 50 !J..1l1.
the PDGFR-a-dependent development of intertubular mesenchy-
mal cells is required for the elongation of collecting ducts.
To keep the mice viable and to avoid the effect of metabolic
imbalance due to renal failure, we selected a short-term injection
schedule in which an intraperitoneal injection of 100 fLg of APAS
was given at 0-2 dpp, and the mice were examined at 3 dpp. With
this schedule, aU APAS-treated mice remained viable and their
body size was comparable to that of control animals (Fig 7D),
although a slight dilatation of renal ducts occurred (Fig 7B). As
shown in Fig 7D, hair development of all the APAS-treated mice
was stunted. A flat-mount preparation of the skin showed that the
number of ha.ir follicles in the skin of the APAS-treated mice was
similar to that of the comrol mice (Fig 7E-H): 170.8 ± 2.S/mm-
and 172.0 ± 2.1/mm2 in the normal and the APAS-treated skins.
respectively. In contrast, although straight hair outgrowth was
observed in the normal skin (Fig 7E, G), many hairs of the
APAS-treated mice remained within the follicles, which were short,
and the number of hairs that grew out to the surface was markedly
reduced (Fig 7F,H).
Histologically, sebaceous glands developed normally in APAS-
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Figure 8. Histology of the trunk skin from the APA5-injected mouse. Sagittal sections of the tJ'ltnk skin 6:om the (A) control and (B-E) 
APA5-mj ected 3-dpp C57BL/6 mice . An ino'aperitoneal injection of 100 }.Lg APA5 was given every day "fter birth, as described in the legcnd to Fig 7. 
Arrowheads indicate eruptive cyst (C), frizzled hair shaft (D), 'Illd normall y deveJoped sebaceous glands (E). (F) Six hah follicles that prescnt distinct stages 
during hair canal formation were selected from 2- or 3-dpp C57BL/ 6 mice. The staging was performed on thc basis of their morphology. An ingressing 
aggregate of matu re kcratinocytes is marked in the second photograph (circle). As shown in the fotll' subsequent pictures, tillS aggrcgate comities frol11 rhe 
upper portion and eventually forms a tube Oll t of which a hair shaft grows. Scale I,ars: (A,B), 100 }.Lm; (C-F) , 25 }.Lm . 
treated mice. The dermis was thin, however , the dermal me sen-
chytne was sparse, and hair folJicles were short and irregular in the 
APAS-treated mice compared with control animals (Fig SA,B). 
More strikingly, hair canal formation was severely disturbed in 
many pelage hair follicles (Fig se-E). The number of well-
developed hair canals in the APAS-treated mice was one fourth that 
of control n1.ice. Secondary to this failure in hair canal formation, 
eruptive cyst formation was also recognized in a considerable 
proportion of the follicles (3 ::':: 1 per 100 follicles) (Fig sq. 
DISCUSSION 
This study describes a new monoclonal antibody, APA5, that 
recognizes murine PDGFR-a and blocks its function. During an 
attempt to discover novel functions ofPDGFR-a, we found highly 
transient expression ofPDGFR-a in the epidermal keratinocytes of 
neonatal skin . Other reports have indicated that PDGFR-O' is 
expressed in the dermis but not in the epidermis (Orr-Urtreger and 
Lonai , 1992; Schatteman el ai, 1992; Ansel el ai, 1993; Pontim et ai, 
1994) ill the fetal and adult stages. Tlus discrepancy between our 
studies and those of other groups is probably based on the fact that 
PDGFR-a expression is restricted to only a few neonatal days. 
Nonetheless, this study demonstrated that PDGFR-O' and its ligand 
arc expressed in the neonatal skin in a contiguous fashion, as 
PDGFR-a was found in both the epidermis and dermal mesen-
chyme, particulaJ'ly in cells surrounding hair follicles, whereas 
PDGF was located witlun h air follicles. Moreover, our APAS 
injection studies showed that PDGFR-O' expressed in the neonatal 
skin is functional in both dermal mesenchyme- and epidermis-hair 
follicle interactions. T he formation of the dermal mesenchym e is 
severely suppressed in the Ph / Ph embryo (On-Urtreger and Lonai , 
1992; Schatteman el ai , 1992) . This eventually resu lts in th e failure 
of hair germ induction . Our results extend this finding in the 
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embryo and demonstrate that PDGF continues to function in the
development of the dermal mesenchyme in neonates. In this
context, it is notable that the development of dermal mesenchyme
was impaired in the mutant mice tabby (Mayer and Green, 1978),
crinkled (Falconer et ai, 1951), and dO/vlIless (Green et ai, 1977),
which have defective hair follicle development. As hair follicles are
the only source ofPDGF in the skin, this impairment might well be
the consequence of a PDGF deficiency in the skin of these mice. The
growth of hair follicle cells lacking PDGFR-a was also suppressed in
the APAS-treated mice. This suggests that the hair follicle and adjacent
mesenchyme fonn a reciprocally interacting unit in which the PDGF
signal plays a role by stimulating the proliferation ofmesenchymal cells
by means of the PDGF expressed in the hair follicles.
In addition to the hair follicle-dermal mesenchyme interaction,
our results demonstrate that PDGF is involved in the follicle-
epidermal interaction, which is required for hair canal formation.
As shown in a selies of figures (Fig SF), hair canal formation
consists of two steps. In the first step, the basal layer of the
epidermis subsides at the site of developing hair follicles to join the
follicular epithelium, and the mature keratinocytes form an ingress-
ing aggregate. In the second step, the l1Jature keratinocytes cornify
to form tubes open to the body surface. Our histologic examination
of the skin of the APAS-treated mice showed that the first step of
hair canal formation was inhibited by blocking the PDGFR-O'
signal. As PDGF expression is linlited to the hair follicle, the timely
expression ofPDGFR-O' in the entire keratinocytes seems sufticient
for selectively triggering keratinocytes in the vicinity of the devel-
oping hair follicles, thereby forming a cell aggregate that eventually
develops into the hair canal at the correct position.
At present, it is difficult to determine how the PDGF signal
regulates tllis process, because only a minor population of the
keratinocytes was stimulated by PDGF, and the PDGF signal exerts
multiple biologic effects. Because the first step of hair canal
formation is the formation of small aggregates of keratinocytes
ingressing toward the follicle, such aggregates could be acllieved by
the PDGF induction of cell growth, enhanced cell motility, or
regulated cell adhesion. According to, a study by Koyama el al
(1994), however, PDGFR-a seems to enllance cell motility far less
than PDGFR-J3. Thus, cell motility might not be directly activated
by PDGFR-a. On the other hand, several studies have indicated
that integrin- or cadherin-mediated cell adhesion can be controlled
by receptor tyrosille ki.nases, including PDGFR-a (Kinashi and
Springer, 1994; Hoschuetzky et ai, 1995; Shiozaki et ai, 1995).
Nevertheless, it is important to identify wllich molecules are
activated by PDGF to regulate the subsequent steps of hair canal
fonnation. One approach is to analyze the mutations that confer a
silllilar phenotype ill hair follicle development but that are not
mapped to the PDGFR-a gene. As far as we have been able to
determine, however, no mutant mice with defective hair canal
f0n113tion have been described, although many hairless mice with
defective hair follicle formation have been reported. In contrast, an
intriguing defect of hair canal formation has been reported as
eruptive vellus hair cyst syndrome, which is partly inheritable
(Esterly et ai, 1977; Piepkorn et ai, 1981; Sti.eRer and Bergfeld,
1980). Thus, it would be of interest to analyze those patients for
PDGFR-O' expression.
Tllis study demonstrates that both PDGFR-a and its ligand are
expressed contiguously in neonatal skin and that they are function-
ally required for the termillal process of hair follicle formation. In
particular, the timely but ubiquitous expression ofPDGFR-a ill the
epidermis, with constitutive but localized expression of PDGFs ill
hair follicles, produced patent canals in the homogeneous epider-
mal layer. This presents a new example of the developmental
strategy by which novel structures can be created at the conect
positions. Hair follicle development might be a process involving a
set of growth factors such as epidermal growth factor, transfonning
growth factor-a, transforming growth factor-J3, keratinocyte
growth factor, and bone morphogenic protein-2 (Hardy, 1992).
Because this study added PDGF to the list of cytokines regularlllg
hair follicle development, we believe that the hair follicle provides
THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
the best model to investigate the llierarchic relations of cytokines
during organogenesis.
Tllis work was sllpp011ed by gralllsji-olll Illejapallese Millisl/}' ojEdllcatiol/, ScieJlce
alld elllllIre (lias. 06283213, 05272102, alld 05454210) alld a grollt frOIll
RIKEN. J,Ve "I{"l1d lille 10 Iltallk Dr. L. Sltllliz (Tlte jachsoll LaborolOlY) for
prof/idillg lite Plt/+ lIlice, Drs. M. Ogawa alld K. lkaijorltelpjlll disCl/ssioll, alld
Ms. S. Nishi/Milia jar excellcul lec/mical assislallce.
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